نتایج جستجو برای: glucagon

تعداد نتایج: 13032  

Journal: :Diabetes 2004
Sajjad A Qureshi Mari Rios Candelore Dan Xie Xiaodong Yang Laurie M Tota Victor D-H Ding Zhihua Li Alka Bansal Corin Miller Sheila M Cohen Guoqiang Jiang Ed Brady Richard Saperstein Joseph L Duffy James R Tata Kevin T Chapman David E Moller Bei B Zhang

Glucagon maintains glucose homeostasis during the fasting state by promoting hepatic gluconeogenesis and glycogenolysis. Hyperglucagonemia and/or an elevated glucagon-to-insulin ratio have been reported in diabetic patients and animals. Antagonizing the glucagon receptor is expected to result in reduced hepatic glucose overproduction, leading to overall glycemic control. Here we report the disc...

Journal: :Diabetes 2017
Nori Geary

Pancreatic glucagon is a 29–amino acid hormone processed from proglucagon by prohormone convertase 2 in the pancreatic a-cells (1). Glucagon’s best-established function is to defend against decreases in glucose availability during fasting, stress, and exercise by stimulating hepatic glycogenolysis phasically and hepatic gluconeogenesis tonically (1–5). Glucagon also increases phasically during ...

Journal: :Clinical science 2008
Xiao C Li Tang-Dong Liao Jia L Zhuo

Clinical studies have shown that patients with early Type 2 diabetes often have elevated serum glucagon rather than insulin deficiency. Imbalance of insulin and glucagon in favouring the latter may contribute to impaired glucose tolerance, persistent hyperglycaemia, microalbuminuria and glomerular injury. In the present study, we tested the hypothesis that long-term glucagon infusion induces ea...

Journal: :Diabetes 2003
Marieke Ruiter Susanne E La Fleur Caroline van Heijningen Jan van der Vliet Andries Kalsbeek Ruud M Buijs

Plasma glucose concentrations display a daily rhythm generated by the hypothalamic biological clock, located in the suprachiasmatic nucleus (SCN). How the SCN orchestrates this rhythm is unknown. Because glucagon stimulates hepatic glucose production, we hypothesized that if glucagon has a daily rhythm, then it may be responsible for the glucose rhythm. From hourly blood samples, we determined ...

Journal: :Diabetes 1981
L Korányi F Péterfy J Szabó A Török M Guóth G Tamás

The effect of gut glucagon-like immunoreactivity (GLI) devoid of pancreatic glucagon was studied in piglets. All glucagon-like peptides with an accessible C-terminal were removed from the gut extract by specific antibodies reacting with the C-terminal of the glucagon molecule. Endogenous secretion of pancreatic and gut glucagon was blocked by somatostatin infusion, and then the purified gut glu...

Journal: :The Journal of clinical investigation 1996
M R Charlton D B Adey K S Nair

Despite the strong association between protein catabolic conditions and hyperglucagonemia, and enhanced glucagon secretion by amino acids (AA), glucagon's effects on protein metabolism remain less clear than on glucose metabolism. To clearly define glucagon's catabolic effect on protein metabolism during AA load, we studied the effects of glucagon on circulating AA and protein dynamics in six h...

Journal: :Journal of lipid research 1974
J N Livingston P Cuatrecasas D H Lockwood

This study is concerned with potential modifications of large fat cells from adult rats (400-450 g) that make them resistant to stimulation by glucagon. The lipolytic capacity and (125)I-labeled glucagon-binding capability of these cells were compared with these properties of small glucagon-sensitive cells from young rats (130-160 g). As determined by maximal stimulation with theophylline, dibu...

Journal: :Diabetes 2000
J C Parker R K McPherson K M Andrews C B Levy J S Dubins J E Chin P V Perry B Hulin D A Perry T Inagaki K A Dekker K Tachikawa Y Sugie J L Treadway

Peptidic glucagon antagonists have been shown to lower blood glucose levels in diabetic models (1-3), but attempts to identify small molecular weight glucagon receptor-binding antagonists have met with little success. Skyrin, a fungal bisanthroquinone, exhibits functional glucagon antagonism by uncoupling the glucagon receptor from adenylate cyclase activation in rat liver membranes (1). We hav...

2015
Rita S. Patarrão W. Wayne Lautt M. Paula Macedo

Glucagon levels are often moderately elevated in diabetes. It is known that glucagon leads to a decrease in hepatic glutathione (GSH) synthesis that in turn is associated with decreased postprandial insulin sensitivity. Given that cAMP pathway controls GSH levels we tested whether insulin sensitivity decreases after intraportal (ipv) administration of a cAMP analog (DBcAMP), and investigated wh...

Journal: :Circulation Research 1969

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید